Inhibiting neurotransmitter reuptake

US9944618B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9944618-B2
Application numberUS-201414776397-A
CountryUS
Kind codeB2
Filing dateMar 10, 2014
Priority dateMar 14, 2013
Publication dateApr 17, 2018
Grant dateApr 17, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

This document relates to compounds as well as methods and materials involved in modulating neurotransmitter reuptake. For example, compounds, methods for synthesizing compounds, and methods for inhibiting neurotransmitter reuptake are provided. Specifically gamma-amino alcohol derivatives that inhibit the reuptake of neurotransmitters such as dopamine, serotonin, epinephrine or norepinephrine are provided as therapeutic agents for the treatment of depression or anxiety in a mammalian subject.

First claim

Opening claim text (preview).

What is claimed is: 1. A compound of formula I: wherein R 1 is selected from naphthalen-2-yl, and phenyl substituted at the 3- or 4-position or 3- and 4-positions with a substituent selected from halogen and lower alkyl; R 2 is a 5- or 6-membered aromatic heterocycle each of which is substituted with substituents selected from halo, methylsulfanyl, methanesulfonyl, hydroxyl, methyl, ethyl, alkoxy, dimethylamino, and 1,1,1-trifluoromethanesulfonamide; optionally, two adjacent alkoxy groups are connected to form a 5- or 6-membered ring; R 3 is hydrogen, hydroxyl, lower alkoxy, or halo; and R 4 is hydrogen or lower alkyl. 2. The compound of claim 1 , wherein R 2 is substituted with one or two substituents. 3. The compound of claim 1 , having the formula Ia or Ib: wherein R a , R b , R c , R d , and R e are selected from hydrogen, lower alkyl, and halo. 4. The compound of claim 3 , wherein at least two of R a , R b , R c , R d , and R e are hydrogen. 5. The compound of claim 4 , wherein the remaining R a , R b , R c , R d , and R e are independently selected from ethyl, chloro, and bromo. 6. The compound of claim 3 , wherein R a , R d , and R e are hydrogen; and R b and R c are independently selected from ethyl, chloro, and bromo. 7. A compound of formula II: wherein R 2 is a 5- or 6-membered aromatic heterocycle each of which is substituted with substituents selected from halo, methylsulfanyl, methanesulfonyl, ethyl, alkoxy, dimethylamino, and 1,1,1-trifluoromethanesulfonamide; R 5 is hydrogen or lower alkyl; and R b and R c are independently hydrogen, halo, or lower alkyl. 8. The compound of claim 7 , wherein each of R b and R c is not hydrogen. 9. A compound of formula I: wherein R 1 is a phenyl substituted at the 3 or 4 position or 3- and 4-positions with a substituent selected from halogen and lower alkyl; R 2 is selected from phenyl and a 5- or 6-membered aromatic heterocycle each of which is optionally substituted with substituents selected from halo, methylsulfanyl, methanesulfonyl, hydroxyl, methyl, ethyl, alkoxy, dimethylamino, and 1,1,1-trifluoromethanesulfonamide; optionally, two adjacent alkoxy groups are connected to form a 5- or 6-membered ring; R 3 is hydrogen, hydroxyl, lower alkoxy, or halo; and R 4 is hydrogen or lower alkyl, wherein said compound has the formula Ia: wherein at least two of R a , R b , R c , R d , and R e are hydrogen, and wherein the remaining R a , R b , R c , R d , and R e are independently selected from ethyl, chloro, and bromo. 10. A compound of formula I: wherein R 1 is a phenyl substituted at the 3 or 4 position or 3- and 4-positions with a substituent selected from halogen and lower alkyl; R 2 is selected from phenyl and a 5- or 6-membered aromatic heterocycle each of which is optionally substituted with substituents selected from halo, methylsulfanyl, methanesulfonyl, hydroxyl, methyl, ethyl, alkoxy, dimethylamino, and 1,1,1-trifluoromethanesulfonamide; optionally, two adjacent alkoxy groups are connected to form a 5- or 6-membered ring; R 3 is hydrogen, hydroxyl, lower alkoxy, or halo; and R 4 is hydrogen or lower alkyl, wherein said compound has the formula Ia: wherein R a , R d , and R e are hydrogen; and R b and R c are independently selected from ethyl, chloro, and bromo.

Assignees

Inventors

Classifications

  • having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom · CPC title

  • having no double bonds between ring members or between ring members and non-ring members · CPC title

  • from aromatic carboxylic acids · CPC title

  • C07D333/28Primary

    Halogen atoms · CPC title

  • having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9944618B2 cover?
This document relates to compounds as well as methods and materials involved in modulating neurotransmitter reuptake. For example, compounds, methods for synthesizing compounds, and methods for inhibiting neurotransmitter reuptake are provided. Specifically gamma-amino alcohol derivatives that inhibit the reuptake of neurotransmitters such as dopamine, serotonin, epinephrine or norepinephrine a…
Who is the assignee on this patent?
Mayo Found Medical Education & Res, Virginia Tech Intellectual Properties Inc
What technology area does this patent fall under?
Primary CPC classification C07D333/28. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Apr 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).